Madrigal Pharmaceuticals (MDGL) Assets (2019 - 2025)
Historic Assets for Madrigal Pharmaceuticals (MDGL) over the last 14 years, with Q3 2025 value amounting to $1.4 billion.
- Madrigal Pharmaceuticals' Assets rose 2694.51% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 2694.51%. This contributed to the annual value of $1.0 billion for FY2024, which is 6271.2% up from last year.
- According to the latest figures from Q3 2025, Madrigal Pharmaceuticals' Assets is $1.4 billion, which was up 2694.51% from $1.0 billion recorded in Q2 2025.
- Madrigal Pharmaceuticals' Assets' 5-year high stood at $1.4 billion during Q3 2025, with a 5-year trough of $158.6 million in Q3 2022.
- Over the past 5 years, Madrigal Pharmaceuticals' median Assets value was $332.4 million (recorded in 2023), while the average stood at $598.0 million.
- Its Assets has fluctuated over the past 5 years, first plummeted by 4793.38% in 2022, then soared by 35101.99% in 2024.
- Madrigal Pharmaceuticals' Assets (Quarter) stood at $273.3 million in 2021, then skyrocketed by 32.65% to $362.6 million in 2022, then soared by 76.67% to $640.5 million in 2023, then soared by 62.71% to $1.0 billion in 2024, then surged by 30.72% to $1.4 billion in 2025.
- Its Assets was $1.4 billion in Q3 2025, compared to $1.0 billion in Q2 2025 and $996.6 million in Q1 2025.